<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>15</volume><submitter>Zhu Z</submitter><pubmed_abstract>&lt;h4>Background&lt;/h4>Triphala, is a composite of three individual botanical drugs: &lt;i>Terminalia chebula&lt;/i>, &lt;i>Terminalia bellirica&lt;/i>, and &lt;i>Emblica officinalis&lt;/i>. It exhibits properties such as heatclearing, anti-inflammatory, anti-fatigue, antioxidant, and antibacterial effects,making it extensively utilized in India and Tibet. It has been found to exhibitinhibitory effects on &lt;i>Helicobacter pylori&lt;/i> (&lt;i>H. pylori&lt;/i>); however, further comprehensive research is still needed to elucidate its specific antibacterial mechanism. The present study investigates the in vitro antibacterial activity and antibacterial mechanism of Triphala against &lt;i>H. pylori&lt;/i>.&lt;h4>Methods&lt;/h4>Ours research investigates the &lt;i>in vitro&lt;/i> inhibitory activity of Triphala on multiple standard and clinica</pubmed_abstract><journal>Frontiers in pharmacology</journal><pagination>1438193</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC11611552</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Preliminary investigation of the &lt;i>in vitro&lt;/i> anti-&lt;i>Helicobacter pylori&lt;/i> activity of Triphala.</pubmed_title><pmcid>PMC11611552</pmcid><pubmed_authors>Zhang G</pubmed_authors><pubmed_authors>Li H</pubmed_authors><pubmed_authors>Su B</pubmed_authors><pubmed_authors>Zhu Z</pubmed_authors><pubmed_authors>Feng Z</pubmed_authors><pubmed_authors>Chen M</pubmed_authors><pubmed_authors>Yao M</pubmed_authors><pubmed_authors>Hao Y</pubmed_authors><pubmed_authors>Zhang L</pubmed_authors><pubmed_authors>Pang Y</pubmed_authors><pubmed_authors>Jia J</pubmed_authors><pubmed_authors>Zou Y</pubmed_authors><pubmed_authors>Lai Y</pubmed_authors><pubmed_authors>Wei R</pubmed_authors><pubmed_authors>Ou L</pubmed_authors></additional><is_claimable>false</is_claimable><name>Preliminary investigation of the &lt;i>in vitro&lt;/i> anti-&lt;i>Helicobacter pylori&lt;/i> activity of Triphala.</name><description>&lt;h4>Background&lt;/h4>Triphala, is a composite of three individual botanical drugs: &lt;i>Terminalia chebula&lt;/i>, &lt;i>Terminalia bellirica&lt;/i>, and &lt;i>Emblica officinalis&lt;/i>. It exhibits properties such as heatclearing, anti-inflammatory, anti-fatigue, antioxidant, and antibacterial effects,making it extensively utilized in India and Tibet. It has been found to exhibitinhibitory effects on &lt;i>Helicobacter pylori&lt;/i> (&lt;i>H. pylori&lt;/i>); however, further comprehensive research is still needed to elucidate its specific antibacterial mechanism. The present study investigates the in vitro antibacterial activity and antibacterial mechanism of Triphala against &lt;i>H. pylori&lt;/i>.&lt;h4>Methods&lt;/h4>Ours research investigates the &lt;i>in vitro&lt;/i> inhibitory activity of Triphala on multiple standard and clinica</description><dates><release>2024-01-01T00:00:00Z</release><publication>2024</publication><modification>2026-04-08T19:49:58.087Z</modification><creation>2025-04-06T00:33:01.012Z</creation></dates><accession>S-EPMC11611552</accession><cross_references><pubmed>39629075</pubmed><doi>10.3389/fphar.2024.1438193</doi></cross_references></HashMap>